Asahi Kasei Pharma Corp. Deal History & Licensing Activity
Asahi Kasei Pharma Corp. is a life sciences. Over the past three years, Asahi Kasei Pharma Corp. has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Small Molecules
Focus Area
Other
Asahi Kasei Pharma Corp. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Asahi Kasei Pharma Corp. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| lead HiSAP compounds | Alchemedicine Inc. | Small Molecules | Unknown | license | Feb 2026 |
Asahi Kasei Pharma Corp. Pipeline Focus
Therapeutic areas and modalities where Asahi Kasei Pharma Corp. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Asahi Kasei Pharma Corp. Strategic Signals
Key indicators of Asahi Kasei Pharma Corp.'s licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Asahi Kasei Pharma Corp.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Other assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Asahi Kasei Pharma Corp. Licensing & Deal Activity
Asahi Kasei Pharma Corp. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Asahi Kasei Pharma Corp. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Asahi Kasei Pharma Corp. include Other (2 deals and trials). In terms of modality, Asahi Kasei Pharma Corp. has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Asahi Kasei Pharma Corp. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Asahi Kasei Pharma Corp.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.